RxDoctor Payments Data
★ My doctorsLook up a doctor →

Penny Glickman

Endocrinology, Diabetes & Metabolism · Maitland, FLNPI 1619975638

Payments from drug & device makers

$71,033in general payments, 2019–2025

Across 379 payments — averaging $187.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$41K
  • Lexicon Pharmaceuticals, Inc.$18K
  • Tandem Diabetes Care, Inc.$4K
  • Novo Nordisk$986
  • Sanofi-aventis U.S. LLC$740
  • Lilly USA, LLC$676
  • plus $6K from 43 others

What the payments were for

  • Speaking & faculty fees$4,00032%
  • Food & beverage$8,33567%
  • Education$180%
  • Gifts$590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi US Services Inc.21$40,753
Lexicon Pharmaceuticals, Inc.1$17,867
Tandem Diabetes Care, Inc.21$4,262
Novo Nordisk47$986
Sanofi-aventis U.S. LLC21$740
Lilly USA, LLC28$676
Amgen(2 entities)21$598
IBSA Pharma Inc.22$413
AbbVie20$365
BETA Bionics, Inc.7$359
Boehringer Ingelheim17$283
Radius Health, Inc.12$273
AstraZeneca(2 entities)13$268
Cequr Corporation2$263
Insulet Corporation7$262
Abbott5$253
Amneal Pharmaceuticals LLC12$210
Johnson & Johnson8$181
Bayer12$181
Sequel Med Tech, LLC2$134
Pfizer6$126
Merck10$126
Xeris Pharmaceuticals, Inc.6$123
Corcept Therapeutics6$107
Dexcom, Inc.6$105
Recordati_rare_diseases_inc.3$103
Amarin Pharma, Inc.7$97
Companion Medical, Inc.1$74
Shire North American Group Inc1$71
Ipsen Biopharmaceuticals, Inc2$69
Rhythm Pharmaceuticals, Inc.2$65
Mannkind Corporation1$59
Ascendis Pharma Endocrinology Inc2$59
Globus Medical2$58
Neurocrine Biosciences, Inc.2$55
Kyowa Kirin, Inc.3$53
Madrigal Pharmaceuticals2$46
Antares Pharma, Inc.2$45
Medtronic(2 entities)3$38
Endo Pharmaceuticals Inc.2$36
Valeritas, Inc.2$28
Senseonics, Incorporated2$26
Amphastar Pharmaceuticals, Inc.1$25
Astellas Pharma US Inc1$21
Almatica Pharma LLC1$21
Ascensia Diabetes Care US Inc.1$19
Lifescan, Inc.1$16
Renalytix AI, Inc.1$16
Takeda Pharmaceuticals U.S.A., Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,033 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$168,579
JardianceEmpagliflozin113$147,425
MounjaroTirzepatide65$83,735
TrulicityDulaglutide36$56,601
SynthroidLevothyroxine Sodium599$47,827
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/729$37,844
Tresiba Flextouch U-100Insulin Degludec33$22,980
FarxigaDapagliflozin Propanediol16$17,274
JanuviaSitagliptin Phosphate12$16,300
HumalogInsulin Lispro40$8,984
Humalog Kwikpen U-100Insulin Lispro21$7,596
LevoxylLevothyroxine Sodium129$4,258
TirosintLevothyroxine Sodium13$4,233
Novolog FlexpenInsulin Aspart17$4,126
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$986$168,579106 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$676$149,320141 claims
Boehringer IngelheimJardiance$283$147,425113 claims
AbbVieSynthroid$365$47,827599 claims
AstraZenecaFarxiga$268$17,27416 claims
MerckJanuvia$126$16,30012 claims
PfizerLevoxyl$126$4,258129 claims
IBSA Pharma Inc.Tirosint$413$4,23313 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$210$3,627176 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

Other endocrinology, diabetes & metabolism in Maitland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →